Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and SurvivalThomas A. Werfel, Craig L. Duvall, Shan Wang et al.|Cancer Research|2018Cited by 82
Kupffer cell release of platelet activating factor drives dose limiting toxicities of nucleic acid nanocarriersMeredith A. Jackson, Craig L. Duvall, Alyssa M. Hasty et al.|Biomaterials|2020Cited by 20
Kupffer Cell Release of Platelet Activating Factor Drives Dose Limiting Toxicities of Nucleic Acid NanocarriersMeredith A. Jackson, Craig L. Duvall, Shrusti S. Patel et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 2
Data from Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and SurvivalThomas A. Werfel, Craig L. Duvall, Shan Wang et al.|Unknown|2023Cited by 0
Data from Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and SurvivalThomas A. Werfel, Craig L. Duvall, Shan Wang et al.|Unknown|2023Cited by 0